These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33848558)

  • 1. Ferrocene-containing polymersome nanoreactors for synergistically amplified tumor-specific chemodynamic therapy.
    Wang Y; Zhang S; Wang J; Zhou Q; Mukerabigwi JF; Ke W; Lu N; Ge Z
    J Control Release; 2021 May; 333():500-510. PubMed ID: 33848558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH/GSH dual-responsive supramolecular nanomedicine for hypoxia-activated combination therapy.
    Du C; Wang C; Jiang SH; Zheng X; Li Z; Yao Y; Ding Y; Chen T; Yi H
    Biomater Sci; 2023 Aug; 11(16):5674-5679. PubMed ID: 37439102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymersome nanoreactors with tumor pH-triggered selective membrane permeability for prodrug delivery, activation, and combined oxidation-chemotherapy.
    Mukerabigwi JF; Yin W; Zha Z; Ke W; Wang Y; Chen W; Japir AAMM; Wang Y; Ge Z
    J Control Release; 2019 Jun; 303():209-222. PubMed ID: 31026547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Polymersome Nanoreactors with Tumor-Specific Activable Cascade Reactions for Cooperative Cancer Therapy.
    Ke W; Li J; Mohammed F; Wang Y; Tou K; Liu X; Wen P; Kinoh H; Anraku Y; Chen H; Kataoka K; Ge Z
    ACS Nano; 2019 Feb; 13(2):2357-2369. PubMed ID: 30699292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
    Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/Chemotherapy.
    Li J; Li Y; Wang Y; Ke W; Chen W; Wang W; Ge Z
    Nano Lett; 2017 Nov; 17(11):6983-6990. PubMed ID: 28977746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular PEG-DNA-Ferrocene Nanogels for Synergistically Amplified Chemodynamic Therapy via Cascade Reactions.
    Yan Z; Duan Z; Liu S; Zhao Z
    Biomacromolecules; 2024 Nov; 25(11):7123-7133. PubMed ID: 39401173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multivalent polyphenol-metal-nanoplatform for cascade amplified chemo-chemodynamic therapy.
    Li S; Zhao Y; Ma W; Wang D; Liu H; Wang W; Peng D; Yu CY; Wei H
    Acta Biomater; 2024 Jan; 173():389-402. PubMed ID: 37967695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tumor microenvironment-responsive poly(amidoamine) dendrimer nanoplatform for hypoxia-responsive chemo/chemodynamic therapy.
    Hao Y; Gao Y; Fan Y; Zhang C; Zhan M; Cao X; Shi X; Guo R
    J Nanobiotechnology; 2022 Jan; 20(1):43. PubMed ID: 35062953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Mesoporous Hollow Cobalt Sulfide Nanoreactors for Synergistic Chemodynamic/Photodynamic/Photothermal Therapy with Enhanced Efficacy.
    Li X; He M; Zhou Q; Dutta D; Lu N; Li S; Ge Z
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):50601-50615. PubMed ID: 36335599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Glucose/Oxygen-Exhausting Nanoreactor for Starvation- and Hypoxia-Activated Sustainable and Cascade Chemo-Chemodynamic Therapy.
    Guo Y; Jia HR; Zhang X; Zhang X; Sun Q; Wang SZ; Zhao J; Wu FG
    Small; 2020 Aug; 16(31):e2000897. PubMed ID: 32537936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib prodrug catalytic nanoreactor for chemo/chemodynamic therapy and macrophage re-education.
    Huang Y; Guan Z; Ren L; Luo Y; Chen M; Sun Y; He Y; Zeng Z; Dai X; Jiang J; Huang Z; Zhao C
    J Control Release; 2022 Oct; 350():332-349. PubMed ID: 36028045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
    Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable hollow mesoporous bimetallic nanoreactors to boost chemodynamic therapy.
    Shi Y; Chang L; Pan C; Zhang H; Yang Y; Wu A; Zeng L
    J Colloid Interface Sci; 2024 Feb; 656():93-103. PubMed ID: 37984174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
    Tian H; Zhang M; Jin G; Jiang Y; Luan Y
    J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated Polymer-Ferrocence Nanoparticle as an NIR-II Light Powered Nanoamplifier to Enhance Chemodynamic Therapy.
    He Y; Jin X; Guo S; Zhao H; Liu Y; Ju H
    ACS Appl Mater Interfaces; 2021 Jul; 13(27):31452-31461. PubMed ID: 34197086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Pot Rapid Synthesis of Cu
    Li Q; Yu J; Lin L; Zhu Y; Wei Z; Wan F; Zhang X; He F; Tian L
    ACS Appl Mater Interfaces; 2023 Apr; 15(13):16482-16491. PubMed ID: 36972557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction.
    Liu X; Liu J; Meng C; Zhu P; Liu X; Qian J; Ling S; Zhang Y; Ling Y
    ACS Appl Mater Interfaces; 2021 Nov; 13(45):53574-53585. PubMed ID: 34729975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Assessment of Enhanced Chemodynamic Therapy by an FeMnO
    Dirersa WB; Kan TC; Getachew G; Wibrianto A; Ochirbat S; Rasal A; Chang J; Chang JY
    ACS Appl Mater Interfaces; 2023 Dec; 15(48):55258-55275. PubMed ID: 38013418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
    Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.